MTOR and ovarian carcinoma: Indeed, MFN2 overexpression enhances mitochondrial fusion, reduces ROS generation, activates AMPK, inhibits mTOR, and promotes autophagy, ultimately suppressing ovarian cancer progression.448 Mitochondrial fragmentation is also induced by the hypoxic tumor microenvironment, which leads to mTOR signaling activation.